Amyloid Beta-directed Antibodies

All categories
DBCAT005532Therapeutic category

Monoclonal antibodies directed towards amyloid beta plaques. A DrugBank category of 3 drugs. 3 of them are approved.

Also known as
Amyloid Beta-directed Antibody
Drugs

What you can answer from here — as of July 13, 2022

3DrugsEach linked to its full drug card
Listed above
2Drug targetsEvery drug–target pair in the class, with bond type
Sign in
13Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Amyloid Beta-directed Antibodies share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In